The PERCIVIA Development Center develops the PER.C6^® human cell line for recombinant proteins. PERCIVIA offers an integrated technology platform for protein production and provides customers a hands-on experience of the PER.C6^® technology.

The PER.C6^® platform encompasses cell line generation technology, cell culture development, up and downstream processes, design, scale-up, technology transfer, and regulatory support. High yields, in combination with the fully human glycosylation properties, make the PER.C6^® cell line an attractive platform for the production of proteins, including monoclonal antibodies.

PERCIVIA, LLC
One Hampshire Street,
5th Floor
Cambridge, MA 02139 USA

Ph: (617) 301-8800
Fax: (617) 301-8801
E-mail: info@percivia.com